Application 218344
- Type
- ANDA
- Sponsor
- EPIC PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FAMOTIDINE | FAMOTIDINE | FOR SUSPENSION;ORAL | 40MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218344-001 | FAMOTIDINE | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218344-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | 2680178bc6a6… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | d8e5a09893c0… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218344-001 | FAMOTIDINE | 40MG/5ML | FOR SUSPENSION / ORAL | AB | 2024-10-16 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218344-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218344-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218344-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218344-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218344-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218344-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218344-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218344-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218344-001 | AB | 1 | 2680178bc6a6… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218344-001 | AB | 1 | d8e5a09893c0… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218344-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FAMOTIDINE | FAMOTIDINE | NuCare Pharmaceuticals,Inc. | fd271deb-c748-bf26-e053-6294a90a11aa | 2024-06-28 | Warnings, Adverse reactions | FAMOTIDINE FAMOTIDINE |
| Famotidine | FAMOTIDINE | NuCare Pharmaceuticals,Inc. | 60cd0973-f74e-2b70-e053-2a91aa0a4361 | 2024-06-06 | Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | A-S Medication Solutions | 0abfc8e6-7fdf-4828-89f4-2202002f8489 | 2024-06-03 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | A-S Medication Solutions | 75a334ee-48b9-47e7-8225-6e595bed8a74 | 2024-06-03 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Pepcid | FAMOTIDINE | Bausch Health US LLC | a06502d9-7903-4f37-833e-e5763d502def | 2024-06-01 | Warnings, Adverse reactions | FAMOTIDINE |
| Famotidine | FAMOTIDINE | Rising Pharma Holdings, Inc. | 15b87f7f-1abf-4d8a-bdbe-03bea0021a68 | 2024-05-29 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | VKT Pharma Private Limited | 1c2cfb3c-eaa0-403f-9589-d706afc06f51 | 2024-05-22 | Warnings | Famotidine FAMOTIDINE |
| Maximum Strength Acid Reducer | FAMOTIDINE | TARGET CORPORATION | 07a924f1-14cc-4e7d-e063-6394a90ac7f3 | 2024-05-13 | Warnings | FAMOTIDINE |
| Zantac 360 | FAMOTIDINE | Navajo Manufacturing Company Inc. | e328c59c-baed-0e4e-e053-2995a90ab85c | 2024-04-15 | Warnings | FAMOTIDINE |
| FAMOTIDINE | FAMOTIDINE | Asclemed USA, Inc. | 69bd5340-298b-46ca-83c7-0b5ef233f9c5 | 2024-04-12 | Warnings, Adverse reactions | FAMOTIDINE FAMOTIDINE |
| Famotidine | FAMOTIDINE | Hikma Pharmaceuticals USA Inc. | 1fdf16e5-145d-4c19-a318-fc6c10794b50 | 2024-04-09 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| famotidine | FAMOTIDINE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 6daf1ebe-b0a2-4413-bf25-3de6eb64b0c6 | 2024-03-27 | Warnings | famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Direct_Rx | 138d9ed1-2f8f-d19d-e063-6394a90a695d | 2024-03-13 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| FAMOTIDINE | FAMOTIDINE | NuCare Pharmaceuticals,Inc. | 13168d9e-0697-e5fb-e063-6294a90a69ba | 2024-03-07 | Warnings, Adverse reactions | FAMOTIDINE FAMOTIDINE |
| Maximum Strength Acid Reducer | FAMOTIDINE | TIME CAP LABORATORIES,INC | fe25e1e2-7158-6fe0-e053-6394a90a3bb1 | 2024-03-06 | Warnings | FAMOTIDINE |
| Famotidine | FAMOTIDINE | DR. REDDY'S LABORATORIES INC | 88ac92eb-5684-46c8-8cd2-3d4aefee26cf | 2024-02-22 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Amneal Pharmaceuticals NY LLC | 443e8ea6-7d51-4db7-8f0b-7a854d45bf23 | 2024-02-13 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | VKT Pharma Private Limited | 4e5db906-992f-476b-9d97-63a4c582bbdc | 2024-01-25 | Warnings | Famotidine FAMOTIDINE |
| Famotidine | FAMOTIDINE | Lifestar Pharma LLC | 044a510f-33df-4484-8f07-d821f52b9376 | 2024-01-22 | Warnings, Adverse reactions | Famotidine FAMOTIDINE |
| Acid Reducer | FAMOTIDINE | Allegiant Health | adc2721d-2ca7-4a47-bae1-be298fa1c155 | 2024-01-16 | Warnings | FAMOTIDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.